title: Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation?
authors.affiliation: Virchow Clinic, Department of Surgery, Berlin, Germany.
authors.forename: O
authors.initials: O
authors.lastname: Guckelberger
authors.forename: J M
authors.initials: JM
authors.lastname: Langrehr
authors.forename: W O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: R
authors.initials: R
authors.lastname: Luesebrink
authors.forename: H P
authors.initials: HP
authors.lastname: Lemmens
authors.forename: B
authors.initials: B
authors.lastname: Kratschmer
authors.forename: S
authors.initials: S
authors.lastname: Jonas
authors.forename: M
authors.initials: M
authors.lastname: Knoop
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D015415:Biomarkers; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology*; D003430:Cross-Sectional Studies; D016572:Cyclosporine / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D006943:Hyperglycemia / Q000453:epidemiology; D006973:Hypertension / Q000453:epidemiology; D015228:Hypertriglyceridemia / Q000453:epidemiology; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D009765:Obesity / Q000453:epidemiology; D015995:Prevalence; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects*
chemical_list: D015415:Biomarkers; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus